Tricuspid atresia primary prevention

Tricuspid atresia Microchapters
Home
Patient Information
Overview
Pathophysiology
Causes
Differentiating Tricuspid Atresia from other Disorders
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography
Cardiac Catheterization
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Special Scenarios
Pregnancy
Case Studies
Case #1
Tricuspid atresia primary prevention On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Tricuspid atresia primary prevention All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Tricuspid atresia primary prevention
CDC on Tricuspid atresia primary prevention
Tricuspid atresia primary prevention in the news
Blogs on Tricuspid atresia primary prevention
Directions to Hospitals Treating Type page name here
Risk calculators and risk factors for Tricuspid atresia primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor-In-Chief:; Keri Shafer, M.D. [2] Priyamvada Singh, MBBS [3]; Assistant Editor-In-Chief: Kristin Feeney, B.S. [4]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Prevention

• Effective measures for the primary prevention of tricuspid atresia include fetal echocardiography and sonography in 18th weeks of pregnancy for prenatal screening.
• Once diagnosed and surgically treated, post operated patients with Fontan palliative shunt should be evaluated by cardiac MRI. Follow up maybe about the complications of Fontan shunt including:

• • Exercise intolerance due to ventricular failure,

• • Pericardial and pleural effusion, chylothorax and protein-losing enteropathy due to lymphatic dysfunction

• • Pulmonary emboli, blood clot formation in shunt

• • Liver failure and portal hypertension as a result of increased pressure in the shunt.

• • leakage of anastomosis and pulmonary hypertension.

• • Right atrium dilation and arrhythmia